Stockreport

Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia [Yahoo! Finance]

Quince Therapeutics, Inc.  (QNCX) 
PDF Fri, February 7, 2025 at 2:00 PM GMT+1 7 min read In This Article QNCX Phase 3 NEAT clinical trial nearing 50% enrollment; company reiterates expectation of enr [Read more]